These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34824998)

  • 1. Role of Rab GTPases in Hepatocellular Carcinoma.
    Yang CC; Meng GX; Dong ZR; Li T
    J Hepatocell Carcinoma; 2021; 8():1389-1397. PubMed ID: 34824998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer.
    Jin H; Tang Y; Yang L; Peng X; Li B; Fan Q; Wei S; Yang S; Li X; Wu B; Huang M; Tang S; Liu J; Li H
    Front Cell Dev Biol; 2021; 9():648384. PubMed ID: 34141705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Cell Rab GTPases in Hepatitis B Virus Infection.
    Zeyen L; Prange R
    Front Cell Dev Biol; 2018; 6():154. PubMed ID: 30510928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large Rab GTPase family in a small GTPase world.
    Srikanth S; Woo JS; Gwack Y
    Small GTPases; 2017 Jan; 8(1):43-48. PubMed ID: 27221160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities.
    Agola JO; Jim PA; Ward HH; Basuray S; Wandinger-Ness A
    Clin Genet; 2011 Oct; 80(4):305-18. PubMed ID: 21651512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a.
    Sheng Y; Li J; Zou C; Wang S; Cao Y; Zhang J; Huang A; Tang H
    Arch Virol; 2014 Sep; 159(9):2397-410. PubMed ID: 24788845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration.
    Arrazola Sastre A; Luque Montoro M; Lacerda HM; Llavero F; Zugaza JL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rab GTPases and Membrane Trafficking in Neurodegeneration.
    Kiral FR; Kohrs FE; Jin EJ; Hiesinger PR
    Curr Biol; 2018 Apr; 28(8):R471-R486. PubMed ID: 29689231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.
    Tan YL; Chen WN
    World J Gastroenterol; 2014 May; 20(20):5973-86. PubMed ID: 24876720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
    Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
    Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Rab Proteins for the Life Cycle of Hepatitis C Virus.
    Elgner F; Hildt E; Bender D
    Front Cell Dev Biol; 2018; 6():166. PubMed ID: 30564577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs: Key players in virus-associated hepatocellular carcinoma.
    Sadri Nahand J; Bokharaei-Salim F; Salmaninejad A; Nesaei A; Mohajeri F; Moshtzan A; Tabibzadeh A; Karimzadeh M; Moghoofei M; Marjani A; Yaghoubi S; Keyvani H
    J Cell Physiol; 2019 Aug; 234(8):12188-12225. PubMed ID: 30536673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex interactions between microRNAs and hepatitis B/C viruses.
    Fan HX; Tang H
    World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of long noncoding RNAs in hepatocellular carcinoma.
    Shi L; Peng F; Tao Y; Fan X; Li N
    Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.
    Liao R; Liu L; Zhou J; Wei X; Huang P
    Front Oncol; 2021; 11():697747. PubMed ID: 34277444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.